首页 > 最新文献

Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery最新文献

英文 中文
The effect of panax ginseng on intimal hyperplasia in rats with abdominal aortic intimal injury. 人参对腹主动脉内膜损伤大鼠内膜增生的影响。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-07-21 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.25611
Doğan Yetüt, Nejat V Olgaç, İhsan Bakır

Background: This study aims to investigate the effects of Panax ginseng (P. ginseng) on intimal hyperplasia following intimal injury induced in the abdominal aortas of rats.

Methods: Twenty-four Wistar Albino rats were divided into four equal groups. Group A was designated as the control group and underwent laparotomy alone. In Group B, following laparotomy, the abdominal aorta was partially transected, and intimal injury was induced proximally using a 2F Fogarty catheter. Groups C and D received 20 mg/kg and 40 mg/kg of P. ginseng, respectively, and both groups underwent the same procedure as Group B. Two samples were collected from all rats with aortic injury: one from the primarily repaired aortic segment and another from the aortic segment with intimal injury caused by a Fogarty catheter. One sample was collected from the control group. The intima and media thicknesses of the collected aortic samples were histopathologically evaluated.

Results: No significant intimal hyperplasia was observed in the primarily repaired aortic segments, and P. ginseng did not have significant effect in these segments (p=0.394 and p=0.580, p=0.180, p>0.05). However, significant intimal hyperplasia developed in the aortic segments with injury induced by the Fogarty catheter (p=0.012, p<0.05). High-dose P. ginseng (40 mg/kg) significantly reduced intimal hyperplasia in these segments (p=0.036, p<0.05), while the low dose (20 mg/kg) did not show statistically significant effect (p=1.000, p>0.05).

Conclusion: Our study results showed that P. ginseng reduced intimal hyperplasia in a dose-dependent manner in rat abdominal aortas.

背景:本研究旨在探讨人参对大鼠腹主动脉损伤后内膜增生的影响。方法:24只Wistar白化大鼠随机分为4组。A组为对照组,单独开腹手术。B组,剖腹手术后,部分切断腹主动脉,采用2F Fogarty导管近端诱导内膜损伤。C组和D组分别给予20 mg/kg和40 mg/kg人参,两组均采用与b组相同的方法,从所有主动脉损伤大鼠中收集两个样本:一个来自主要修复的主动脉段,另一个来自福格蒂导管引起的内膜损伤的主动脉段。从对照组中抽取一个样本。对采集的主动脉内膜和中膜厚度进行组织病理学评估。结果:初步修复主动脉段未见明显内膜增生,人参对修复主动脉段无显著影响(p=0.394、p=0.580、p=0.180、p>0.05)。然而,Fogarty导管损伤后主动脉段内膜增生明显(p=0.012),人参(40 mg/kg)可显著减少主动脉段内膜增生(p=0.036, p0.05)。结论:人参对大鼠腹主动脉内膜增生具有剂量依赖性。
{"title":"The effect of panax ginseng on intimal hyperplasia in rats with abdominal aortic intimal injury.","authors":"Doğan Yetüt, Nejat V Olgaç, İhsan Bakır","doi":"10.5606/tgkdc.dergisi.2025.25611","DOIUrl":"10.5606/tgkdc.dergisi.2025.25611","url":null,"abstract":"<p><strong>Background: </strong>This study aims to investigate the effects of <i>Panax ginseng (P. ginseng)</i> on intimal hyperplasia following intimal injury induced in the abdominal aortas of rats.</p><p><strong>Methods: </strong>Twenty-four Wistar Albino rats were divided into four equal groups. Group A was designated as the control group and underwent laparotomy alone. In Group B, following laparotomy, the abdominal aorta was partially transected, and intimal injury was induced proximally using a 2F Fogarty catheter. Groups C and D received 20 mg/kg and 40 mg/kg of <i>P. ginseng</i>, respectively, and both groups underwent the same procedure as Group B. Two samples were collected from all rats with aortic injury: one from the primarily repaired aortic segment and another from the aortic segment with intimal injury caused by a Fogarty catheter. One sample was collected from the control group. The intima and media thicknesses of the collected aortic samples were histopathologically evaluated.</p><p><strong>Results: </strong>No significant intimal hyperplasia was observed in the primarily repaired aortic segments, and <i>P. ginseng</i> did not have significant effect in these segments (p=0.394 and p=0.580, p=0.180, p>0.05). However, significant intimal hyperplasia developed in the aortic segments with injury induced by the Fogarty catheter (p=0.012, p<0.05). High-dose <i>P. ginseng</i> (40 mg/kg) significantly reduced intimal hyperplasia in these segments (p=0.036, p<0.05), while the low dose (20 mg/kg) did not show statistically significant effect (p=1.000, p>0.05).</p><p><strong>Conclusion: </strong>Our study results showed that P. ginseng reduced intimal hyperplasia in a dose-dependent manner in rat abdominal aortas.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"312-320"},"PeriodicalIF":0.5,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12434582/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term follow-up of valved homografts in right ventricle-to-pulmonary artery reconstruction: A comprehensive case series. 有瓣同种移植物在右心室-肺动脉重建中的长期随访:一个全面的病例系列。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-07-21 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.27057
Osman Nuri Tuncer, Mahsati Akhundova, Eser Doğan, Yüksel Atay

Background: This study aims to evaluate the long-term outcomes of patients undergoing right ventricle-to-pulmonary artery reconstruction with valved homografts.

Methods: A total of 106 patients (49 males, 57 females; median age: 5 years; range, 2 to 49 years) who underwent right ventricle-to-pulmonary artery reconstruction between January 2002 and January 2024 were retrospectively analyzed. The study utilized cryopreserved homografts and surgical procedures were conducted under moderate hypothermic conditions using cardiopulmonary bypass. Homograft failure was defined as the need for reintervention or replacement. The primary outcome measures were overall survival, freedom from conduit replacement rate, and freedom from any required reinterventions rate.

Results: The median follow-up was 7 years. The overall survival rate was 92.5%, with early mortality primarily due to low cardiac output. Freedom from reintervention rates were 90.8%, 84.8%, and 76.3% at three, five, and 10 years, respectively. Thirteen patients required conduit replacement, with pulmonary homografts showing improved durability. Risk factors for homograft failure included pulmonary valve regurgitation treatment, lower patient weight, younger age, and female sex.

Conclusion: This study highlights the excellent survival and durability of valved homografts in cardiac reconstruction, with implications for patient management and surgical decision-making in complex congenital heart disease procedures.

背景:本研究旨在评估有瓣同种异体右心室-肺动脉重建患者的长期预后。方法:回顾性分析2002年1月至2024年1月行右心室-肺动脉重建术的106例患者(男49例,女57例,中位年龄5岁,年龄范围2 ~ 49岁)。该研究使用低温保存的同种移植物,并在中度低温条件下使用体外循环进行外科手术。同种移植物失败被定义为需要再干预或置换。主要结局指标为总生存率、无导管置换率和无任何必要的再干预率。结果:中位随访时间为7年。总生存率为92.5%,早期死亡主要是由于低心输出量。3年、5年和10年的再干预率分别为90.8%、84.8%和76.3%。13例患者需要导管置换,肺同种移植物显示出更好的耐久性。同种异体移植物失败的危险因素包括肺动脉瓣返流治疗、患者体重较轻、年龄较小和女性。结论:本研究突出了同种异体心脏移植在心脏重建中的良好生存和耐久性,对复杂先天性心脏病手术的患者管理和手术决策具有重要意义。
{"title":"Long-term follow-up of valved homografts in right ventricle-to-pulmonary artery reconstruction: A comprehensive case series.","authors":"Osman Nuri Tuncer, Mahsati Akhundova, Eser Doğan, Yüksel Atay","doi":"10.5606/tgkdc.dergisi.2025.27057","DOIUrl":"10.5606/tgkdc.dergisi.2025.27057","url":null,"abstract":"<p><strong>Background: </strong>This study aims to evaluate the long-term outcomes of patients undergoing right ventricle-to-pulmonary artery reconstruction with valved homografts.</p><p><strong>Methods: </strong>A total of 106 patients (49 males, 57 females; median age: 5 years; range, 2 to 49 years) who underwent right ventricle-to-pulmonary artery reconstruction between January 2002 and January 2024 were retrospectively analyzed. The study utilized cryopreserved homografts and surgical procedures were conducted under moderate hypothermic conditions using cardiopulmonary bypass. Homograft failure was defined as the need for reintervention or replacement. The primary outcome measures were overall survival, freedom from conduit replacement rate, and freedom from any required reinterventions rate.</p><p><strong>Results: </strong>The median follow-up was 7 years. The overall survival rate was 92.5%, with early mortality primarily due to low cardiac output. Freedom from reintervention rates were 90.8%, 84.8%, and 76.3% at three, five, and 10 years, respectively. Thirteen patients required conduit replacement, with pulmonary homografts showing improved durability. Risk factors for homograft failure included pulmonary valve regurgitation treatment, lower patient weight, younger age, and female sex.</p><p><strong>Conclusion: </strong>This study highlights the excellent survival and durability of valved homografts in cardiac reconstruction, with implications for patient management and surgical decision-making in complex congenital heart disease procedures.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"272-278"},"PeriodicalIF":0.5,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Para-aortic paraganglioma: Preoperative embolization and surgical resection. 主动脉旁副神经节瘤:术前栓塞和手术切除。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-07-21 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.26752
Hasan Reyhanoğlu, Volkan Çakır

Retroperitoneal paragangliomas are neuroendocrine tumors originating from chromaffin cells in the sympathetic nerves. These tumors are commonly located around the abdominal aorta and inferior vena cava and can cause significant bleeding during surgery due to their hypervascular nature. In such cases, preoperative selective embolization can facilitate tumor resection and reduce both morbidity and mortality. This case report presented a 38-year-old male patient with a retroperitoneal paraganglioma who underwent surgery following preoperative embolization due to tumor hypervascularity.

腹膜后副神经节瘤是一种起源于交感神经嗜铬细胞的神经内分泌肿瘤。这些肿瘤通常位于腹主动脉和下腔静脉周围,由于其高血管性质,可在手术中引起大量出血。在这种情况下,术前选择性栓塞可以促进肿瘤切除,降低发病率和死亡率。本病例报告一例38岁男性腹膜后副神经节瘤患者,因肿瘤血管增生术前栓塞手术。
{"title":"Para-aortic paraganglioma: Preoperative embolization and surgical resection.","authors":"Hasan Reyhanoğlu, Volkan Çakır","doi":"10.5606/tgkdc.dergisi.2025.26752","DOIUrl":"10.5606/tgkdc.dergisi.2025.26752","url":null,"abstract":"<p><p>Retroperitoneal paragangliomas are neuroendocrine tumors originating from chromaffin cells in the sympathetic nerves. These tumors are commonly located around the abdominal aorta and inferior vena cava and can cause significant bleeding during surgery due to their hypervascular nature. In such cases, preoperative selective embolization can facilitate tumor resection and reduce both morbidity and mortality. This case report presented a 38-year-old male patient with a retroperitoneal paraganglioma who underwent surgery following preoperative embolization due to tumor hypervascularity.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"382-385"},"PeriodicalIF":0.5,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421556/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrograde aortic dissection after thoracic endovascular aortic repair. 胸血管内主动脉修复后逆行主动脉夹层。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-07-21 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.25808
Koray Ak, Ece Çalışan, Fatih Öztürk, Sinan Arsan

Endovascular treatment methods are often preferred in suitable patients with complicated acute type B aortic dissection due to the high mortality and morbidity associated with the open surgical procedure. Retrograde aortic dissection is a rare complication of endovascular procedures. Herein, we reported surgical treatment of a retrograde aortic dissection that developed after thoracic endovascular aortic repair in a 53-year-old male patient with a history of liver transplantation two years ago and taking immunosuppressive medication.

由于与开放手术相关的高死亡率和发病率,对于复杂的急性B型主动脉夹层患者,通常首选血管内治疗方法。逆行主动脉夹层是一种罕见的血管内手术并发症。在此,我们报道了一名53岁男性患者的手术治疗逆行主动脉夹层,该患者两年前有肝移植史并服用免疫抑制药物。
{"title":"Retrograde aortic dissection after thoracic endovascular aortic repair.","authors":"Koray Ak, Ece Çalışan, Fatih Öztürk, Sinan Arsan","doi":"10.5606/tgkdc.dergisi.2025.25808","DOIUrl":"10.5606/tgkdc.dergisi.2025.25808","url":null,"abstract":"<p><p>Endovascular treatment methods are often preferred in suitable patients with complicated acute type B aortic dissection due to the high mortality and morbidity associated with the open surgical procedure. Retrograde aortic dissection is a rare complication of endovascular procedures. Herein, we reported surgical treatment of a retrograde aortic dissection that developed after thoracic endovascular aortic repair in a 53-year-old male patient with a history of liver transplantation two years ago and taking immunosuppressive medication.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"386-390"},"PeriodicalIF":0.5,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421555/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors of hemoptysis recurrence after bronchial artery embolization and patient feedbacks. 支气管动脉栓塞后咯血复发的危险因素及患者反馈。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-07-21 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.27140
Bo Yang, Awei Huo, Ling Li, Huaiming Qiu

Background: The aim of this study is to identify risk factors for recurrence of hemoptysis after bronchial artery embolization and to evaluate patient feedbacks on this intervention.

Methods: Between August 2013 and October 2022, a total of 122 patients (83 males, 39 females; mean age: 59.7±17.3 years; range, 13 to 91 years) who underwent bronchial artery embolization were retrospectively analyzed. The endpoint event was hemoptysis recurrence or death. Baseline data of the patients, technical and clinical success rates, complications, postoperative recovery time in hospital and patient satisfaction and re-acceptance rates were evaluated via a questionnaire.

Results: During follow-up, 24 patients died. A total of 50 patients experienced recurrence, and the overall recurrence rate was 40.98%. Patients with embolization of single culprit artery had a higher recurrence-free survival rate (p=0.049). Of 97 respondents, 81 were satisfied with the result of the procedure and 84 gave consent for re-intervention, if necessary.

Conclusion: Bronchial artery embolization is a safe and effective method of hemoptysis suppression, particularly for those with embolization of single culprit artery. Better suppression of hemoptysis and strengthening communication with patients in the perioperative period can improve the patient satisfaction.

背景:本研究的目的是确定支气管动脉栓塞后咯血复发的危险因素,并评估患者对该干预措施的反馈。方法:回顾性分析2013年8月~ 2022年10月行支气管动脉栓塞术的122例患者,其中男83例,女39例,平均年龄59.7±17.3岁,年龄范围13 ~ 91岁。终点事件为咯血复发或死亡。通过问卷调查评估患者的基线数据、技术和临床成功率、并发症、术后住院恢复时间以及患者满意度和再接受率。结果:随访期间死亡24例。50例患者复发,总复发率为40.98%。单罪魁动脉栓塞患者无复发生存率较高(p=0.049)。在97名受访者中,81人对治疗结果感到满意,84人同意在必要时再次干预。结论:支气管动脉栓塞是一种安全有效的抑制咯血的方法,尤其对单罪魁动脉栓塞者更为有效。围手术期更好的抑制咯血,加强与患者的沟通,可提高患者满意度。
{"title":"Risk factors of hemoptysis recurrence after bronchial artery embolization and patient feedbacks.","authors":"Bo Yang, Awei Huo, Ling Li, Huaiming Qiu","doi":"10.5606/tgkdc.dergisi.2025.27140","DOIUrl":"10.5606/tgkdc.dergisi.2025.27140","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study is to identify risk factors for recurrence of hemoptysis after bronchial artery embolization and to evaluate patient feedbacks on this intervention.</p><p><strong>Methods: </strong>Between August 2013 and October 2022, a total of 122 patients (83 males, 39 females; mean age: 59.7±17.3 years; range, 13 to 91 years) who underwent bronchial artery embolization were retrospectively analyzed. The endpoint event was hemoptysis recurrence or death. Baseline data of the patients, technical and clinical success rates, complications, postoperative recovery time in hospital and patient satisfaction and re-acceptance rates were evaluated via a questionnaire.</p><p><strong>Results: </strong>During follow-up, 24 patients died. A total of 50 patients experienced recurrence, and the overall recurrence rate was 40.98%. Patients with embolization of single culprit artery had a higher recurrence-free survival rate (p=0.049). Of 97 respondents, 81 were satisfied with the result of the procedure and 84 gave consent for re-intervention, if necessary.</p><p><strong>Conclusion: </strong>Bronchial artery embolization is a safe and effective method of hemoptysis suppression, particularly for those with embolization of single culprit artery. Better suppression of hemoptysis and strengthening communication with patients in the perioperative period can improve the patient satisfaction.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"357-364"},"PeriodicalIF":0.5,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421540/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors of intraabdominal hypertension in cardiac surgery: A systematic review and meta-analysis. 心脏手术中腹内高压的危险因素:一项系统回顾和荟萃分析。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-07-21 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.27656
Selen Öztürk, Gözde Tekin, Hüseyin Uzandı, Mehmet Kızılay, İbrahim Öztürk

Background: In this review, we discuss the risk factors of intraabdominal hypertension developing after cardiac surgery.

Methods: We used records from electronic databases (PubMed, Scopus, Web of Science and Ovid) between 1980 and 2025. All studies in which possible pre- and intraoperative risk factors (age, sex, hypertension, diabetes mellitus, lung disease, coronary artery bypass grafting, body mass index and, cardiopulmonary bypass duration) were recorded were included in the analysis. The results of the studies were evaluated with a random or fixed effect model depending on the presence of heterogeneity (I2 >25%).

Results: A total of 4,286 articles were found from the database search. After analyzing the abstract and full texts, six articles which met the inclusion criteria and covered 696 patients were included in the analysis. The overall rate of intraabdominal hypertension was 44.68%. Age (standardized mean difference [SMD]: 0.303, 95% confidence interval [CI]: 0.123-0.484, p<0.001), hypertension (odds ratio [OR]=0.524, 95% CI: 0.087-0.960, p=0.019), body mass index (SMD: 0.532, 95% CI: 0.004-1.061, p=0.048), and cardiopulmonary bypass duration (SMD: 0.545, 95% CI: 0.184-0.907, p=0.003) were preoperative risk factors.

Conclusion: The patient's age, hypertension, body mass index, and duration of cardiopulmonary bypass are the risk factors for the development of intraabdominal hypertension after cardiac surgery. However, larger studies are needed to avoid heterogeneity of results.

背景:在这篇综述中,我们讨论了心脏手术后发生腹内高压的危险因素。方法:使用1980 - 2025年间PubMed、Scopus、Web of Science和Ovid等电子数据库的记录。所有记录可能的术前和术中危险因素(年龄、性别、高血压、糖尿病、肺病、冠状动脉旁路移植术、体重指数和体外循环时间)的研究均纳入分析。根据异质性(I2 bb0 25%)的存在,采用随机或固定效应模型对研究结果进行评估。结果:检索到文献4286篇。摘要和全文分析后,符合纳入标准的6篇文献纳入分析,共涉及696例患者。总腹内高压发生率为44.68%。年龄(标准化平均差[SMD]: 0.303, 95%可信区间[CI]: 0.123-0.484)结论:患者年龄、高血压、体重指数、体外循环时间是心脏手术后发生腹内高血压的危险因素。然而,需要更大规模的研究来避免结果的异质性。
{"title":"Risk factors of intraabdominal hypertension in cardiac surgery: A systematic review and meta-analysis.","authors":"Selen Öztürk, Gözde Tekin, Hüseyin Uzandı, Mehmet Kızılay, İbrahim Öztürk","doi":"10.5606/tgkdc.dergisi.2025.27656","DOIUrl":"10.5606/tgkdc.dergisi.2025.27656","url":null,"abstract":"<p><strong>Background: </strong>In this review, we discuss the risk factors of intraabdominal hypertension developing after cardiac surgery.</p><p><strong>Methods: </strong>We used records from electronic databases (PubMed, Scopus, Web of Science and Ovid) between 1980 and 2025. All studies in which possible pre- and intraoperative risk factors (age, sex, hypertension, diabetes mellitus, lung disease, coronary artery bypass grafting, body mass index and, cardiopulmonary bypass duration) were recorded were included in the analysis. The results of the studies were evaluated with a random or fixed effect model depending on the presence of heterogeneity (<i>I<sup>2</sup></i> >25%).</p><p><strong>Results: </strong>A total of 4,286 articles were found from the database search. After analyzing the abstract and full texts, six articles which met the inclusion criteria and covered 696 patients were included in the analysis. The overall rate of intraabdominal hypertension was 44.68%. Age (standardized mean difference [SMD]: 0.303, 95% confidence interval [CI]: 0.123-0.484, p<0.001), hypertension (odds ratio [OR]=0.524, 95% CI: 0.087-0.960, p=0.019), body mass index (SMD: 0.532, 95% CI: 0.004-1.061, p=0.048), and cardiopulmonary bypass duration (SMD: 0.545, 95% CI: 0.184-0.907, p=0.003) were preoperative risk factors.</p><p><strong>Conclusion: </strong>The patient's age, hypertension, body mass index, and duration of cardiopulmonary bypass are the risk factors for the development of intraabdominal hypertension after cardiac surgery. However, larger studies are needed to avoid heterogeneity of results.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"321-328"},"PeriodicalIF":0.5,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What the past echoes, the future dares to ask. 过去的回声,未来才敢问。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-07-21 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.95364
Adem İlkay Diken
{"title":"What the past echoes, the future dares to ask.","authors":"Adem İlkay Diken","doi":"10.5606/tgkdc.dergisi.2025.95364","DOIUrl":"10.5606/tgkdc.dergisi.2025.95364","url":null,"abstract":"","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"271"},"PeriodicalIF":0.5,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421537/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of an atrial septal defect occluder for the closure of an ascending aorta pseudoaneurysm after coronary artery bypass grafting. 房间隔缺损封堵器用于冠状动脉旁路移植术后升主动脉假性动脉瘤的闭合。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-07-21 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.25878
İbrahim Kara, Fatih Toptan, Salih Salihi, Mustafa Tarık Ağaç, Yunus Emre Yazıcı

An aortic pseudoaneurysm is a rare, but serious condition which can result in life-threatening complications. It is usually caused by previous cardiac surgery, trauma, or infection. Due to the high likelihood of rupture with primary surgical intervention, endovascular closure may be performed as the standard of care in eligible cases. In this article, we present a case of a huge aortic pseudoaneurysm with a wide neck which could safely be closed using an atrial septal occluder.

主动脉假性动脉瘤是一种罕见但严重的疾病,可导致危及生命的并发症。它通常是由以前的心脏手术、创伤或感染引起的。由于初级手术干预时血管破裂的可能性很高,在符合条件的病例中,血管内闭合可作为标准护理。在这篇文章中,我们提出了一个巨大的假性动脉瘤与宽颈,可以安全地使用房间隔封堵器关闭。
{"title":"Use of an atrial septal defect occluder for the closure of an ascending aorta pseudoaneurysm after coronary artery bypass grafting.","authors":"İbrahim Kara, Fatih Toptan, Salih Salihi, Mustafa Tarık Ağaç, Yunus Emre Yazıcı","doi":"10.5606/tgkdc.dergisi.2025.25878","DOIUrl":"10.5606/tgkdc.dergisi.2025.25878","url":null,"abstract":"<p><p>An aortic pseudoaneurysm is a rare, but serious condition which can result in life-threatening complications. It is usually caused by previous cardiac surgery, trauma, or infection. Due to the high likelihood of rupture with primary surgical intervention, endovascular closure may be performed as the standard of care in eligible cases. In this article, we present a case of a huge aortic pseudoaneurysm with a wide neck which could safely be closed using an atrial septal occluder.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"397-400"},"PeriodicalIF":0.5,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421551/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimized retrograde approach and device selection with Konar-MF™ for pediatric transcatheter ventricular septal defect closure. 使用Konar-MF™优化逆行入路和器械选择用于儿科经导管室间隔缺损闭合。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-07-21 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.27178
Gamze Vuran, Murat Muhtar Yılmazer, Mehmet Murat, Ceren Karahan, Mertkan Bilen, Mustafa Karaçelik, Timur Meşe

Background: This study aims to evaluate the mid-term outcomes of transcatheter ventricular septal defect closure with the Konar-MF™ device and to investigate the impact of an optimized device selection strategy using a retrograde approach.

Methods: Between January 2019 and November 2023, a total of 58 patients (32 males, 26 females; median age: 4.5 years; range, 8 months to 16 years) who underwent transcatheter closure of ventricular septal defects using the Konar-MF™ device were retrospectively analyzed. Patient demographics, procedural details, and follow-up data were recorded.

Results: Procedural success was achieved in 95% of cases, with a median procedure time of 60 min and fluoroscopy time of 12.6 min. Retrograde implantation was used in 79% of patients, significantly reducing procedural time and minimizing complications associated with an arteriovenous loop. Our refined strategy of selecting smaller devices when anatomically feasible played a crucial role in reducing interference with surrounding cardiac structures, substantially contributing to the absence of complete atrioventricular block in our cohort. Major complications included device embolization, moderate aortic regurgitation due to device dislocation, and right ventricular perforation (each in 1.8% of patients). The median follow-up was 34.5 months. Residual shunt rates were initially 42% on postoperative Day 1, reducing to 1.8% by the end of the follow-up period.

Conclusion: The Konar-MF™ occluder demonstrated high procedural success and acceptable complication rates for perimembranous ventricular septal defect closure. The use of a retrograde approach and a refined device selection strategy were key factors in achieving favorable outcomes, minimizing complications such as atrioventricular block and valve interference. The device offers significant advantages, making it a suitable alternative to surgical ventricular septal defect closure.

背景:本研究旨在评估使用Konar-MF™装置经导管室间隔缺损闭合的中期结果,并研究使用逆行方法优化装置选择策略的影响。方法:回顾性分析2019年1月至2023年11月期间使用Konar-MF™装置行室间隔缺损经导管闭合术的58例患者(男性32例,女性26例,中位年龄4.5岁,范围8个月至16岁)。记录患者人口统计、手术细节和随访数据。结果:95%的病例手术成功,中位手术时间为60分钟,透视时间为12.6分钟。79%的患者采用逆行植入,显著缩短了手术时间,并最大限度地减少了与动静脉环相关的并发症。在解剖学上可行的情况下,我们选择更小的装置的精细策略在减少对周围心脏结构的干扰方面发挥了至关重要的作用,这在我们的队列中大大促进了完全房室传导阻滞的缺失。主要并发症包括器械栓塞、器械脱位引起的中度主动脉反流和右心室穿孔(各占1.8%)。中位随访时间为34.5个月。术后第1天剩余分流率为42%,随访结束时降至1.8%。结论:Konar-MF™闭塞器在膜周室间隔缺损闭合中具有较高的手术成功率和可接受的并发症发生率。逆行入路的使用和精细的器械选择策略是获得良好结果的关键因素,可以最大限度地减少房室传导阻滞和瓣膜干扰等并发症。该装置具有显著的优点,使其成为手术室间隔缺损关闭的合适替代方案。
{"title":"Optimized retrograde approach and device selection with Konar-MF™ for pediatric transcatheter ventricular septal defect closure.","authors":"Gamze Vuran, Murat Muhtar Yılmazer, Mehmet Murat, Ceren Karahan, Mertkan Bilen, Mustafa Karaçelik, Timur Meşe","doi":"10.5606/tgkdc.dergisi.2025.27178","DOIUrl":"10.5606/tgkdc.dergisi.2025.27178","url":null,"abstract":"<p><strong>Background: </strong>This study aims to evaluate the mid-term outcomes of transcatheter ventricular septal defect closure with the Konar-MF™ device and to investigate the impact of an optimized device selection strategy using a retrograde approach.</p><p><strong>Methods: </strong>Between January 2019 and November 2023, a total of 58 patients (32 males, 26 females; median age: 4.5 years; range, 8 months to 16 years) who underwent transcatheter closure of ventricular septal defects using the Konar-MF™ device were retrospectively analyzed. Patient demographics, procedural details, and follow-up data were recorded.</p><p><strong>Results: </strong>Procedural success was achieved in 95% of cases, with a median procedure time of 60 min and fluoroscopy time of 12.6 min. Retrograde implantation was used in 79% of patients, significantly reducing procedural time and minimizing complications associated with an arteriovenous loop. Our refined strategy of selecting smaller devices when anatomically feasible played a crucial role in reducing interference with surrounding cardiac structures, substantially contributing to the absence of complete atrioventricular block in our cohort. Major complications included device embolization, moderate aortic regurgitation due to device dislocation, and right ventricular perforation (each in 1.8% of patients). The median follow-up was 34.5 months. Residual shunt rates were initially 42% on postoperative Day 1, reducing to 1.8% by the end of the follow-up period.</p><p><strong>Conclusion: </strong>The Konar-MF™ occluder demonstrated high procedural success and acceptable complication rates for perimembranous ventricular septal defect closure. The use of a retrograde approach and a refined device selection strategy were key factors in achieving favorable outcomes, minimizing complications such as atrioventricular block and valve interference. The device offers significant advantages, making it a suitable alternative to surgical ventricular septal defect closure.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"301-311"},"PeriodicalIF":0.5,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421569/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical approach to complicated transcatheter aortic valve implantation endocarditis. 复杂经导管主动脉瓣植入性心内膜炎的手术入路。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-07-21 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.26945
Burak Bozkurt, İsmail Yücesin Arslan, Mukan Kağan Kuş, Talib Durak, Mehmet Kaplan
{"title":"Surgical approach to complicated transcatheter aortic valve implantation endocarditis.","authors":"Burak Bozkurt, İsmail Yücesin Arslan, Mukan Kağan Kuş, Talib Durak, Mehmet Kaplan","doi":"10.5606/tgkdc.dergisi.2025.26945","DOIUrl":"10.5606/tgkdc.dergisi.2025.26945","url":null,"abstract":"","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"391-394"},"PeriodicalIF":0.5,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421567/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1